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we have given a conservative interpreta-
tion of our data. We have indicated that
there is a medical need for moisturizers,
and we believe that people who need
them should continue their use.
We hope that an important fall-out
of our publication will be to stimulate
future careful research by epidemiolo-
gists to determine whether or not the
use of moisturizers increases the risk of
skin cancer in humans. Our study also
points out a potential problem for
scientists studying the effects of pre-
ventive or therapeutic agents in a cream
vehicle in humans.
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TO THE EDITOR
In a recent paper by Lu et al. (2008), the
authors reported that moisturizers may
have tumorigenic effects in UVB-pre-
treated mice. The title is misleading; it
implies that the tumors were induced by
topical treatment with moisturizers,
whereas the only cause of the tumors
was chronic UVB-irradiation. The design
of the study cannot reveal any tumori-
genic potential of the topical treatment.
The ingredients of the moisturizers used
in the paper have a very long safety
record (Nash et al., 1996), therefore this
paper raises some important questions.
The authors conducted two con-
trolled studies comparing the effect of
various moisturizers on the development
of skin tumors. A comparison of results
from experiments 1 and 2 reveals severe
inconsistencies. Although both experi-
ments are absolutely identical in their
design, data obtained vary considerably.
The results of the untreated control
group show a high variance of tumor
load and volume 18 weeks after irradia-
tion (Tables 2–5 of the paper). The study
also lacked dose–response relationships
and the inclusion of a typical tumor
promoter as positive control, which
would have given valuable information
on the relevance of the animal model
and the results of the studies. It is
doubtful whether the proposed study
design permits a reliable assessment of
the expected effects.
Statistical reanalysis of the published
data, together with independent ex-
perts, revealed that the major drawback
of the study is the limited reliability of
the average response for all key vari-
ables.
PRECISION OF AVERAGES
In Tables 4 and 5 of the paper, standard
errors are shown to characterize the
precision of the mean values. However,
if the coefficients of variation are
calculated from the published data, it
shows that the mean values are char-
acterized by great uncertainty. A coeffi-
cient of variation of less than 60% is
frequently used as a threshold for
reliable mean values. As all coefficients
of variation, with the exception of the
combined control, are far beyond 60%,
the mean values should be regarded as
meaningless (Table 1).
VALIDITY OF AVERAGES
Lu et al. derived the values for ‘‘tumors
per mouse’’ by dividing all observed
tumors in a given group by the
number of mice in the respective group
and not only by the number of mice that
actually developed tumors. This causes
a misleading picture. For example, 2 of
27 mice in the untreated group (7.4%)
in experiment 2 developed squamous-
cell papillomas, compared with 3 of 29
(10.3%) in the Eucerin group. The
corresponding Table 4 of the paper
shows 0.11 tumors on average for the
untreated group but 0.14 for Eucerin.
However, total (untreated) tumors were
approximately 0.11 27¼2.97, which
is 1.49 on average per affected mouse.
Total (Eucerin) tumors were approxi-
mately 0.1429¼4.06, leading to
1.35 on average per affected mouse.Abbreviations: SD, standard deviation; test no., test number
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COMBINATION OF CONTROL
GROUPS
A combination of two groups after
inspection of the data (untreated and
water) has led to an increase in sample
size to 57 mice for the combined group.
Consequently, the sample size of the
combined group is highly unbalanced
in comparison to the other groups and
the standard error of the mean in the
combined group is reduced severely
compared to the water and untreated
group. This leads to inefficient statisti-
cal tests and must be regarded as a
major weakness of the entire data
analyses.
EXPLORATORY TWO-SAMPLE TESTS
A comparison of the results upon
completion of the entire study after 17
weeks with a series of exploratory
two-sample t-tests, using means and
standard deviation in the paper, reveals
the following results: all pair-wise
comparisons, with the exception of
Dermovan, lead to means indistinguish-
able from the untreated group (Table 2).
With multiplicity adjustment even Der-
movan would not be different from
untreated.
SIGNIFICANCE OF PERCENTAGE
CHANGES
Main conclusions of the study are based
on the ratio of highly imprecise
averages.
In the abstract, the authors report
increases in the formation of tumors of
69% (Dermabase), 95% (Dermovan),
24% (Eucerin), and 58% (Vanicream).
All comparisons are made with regard
to the combined group. If the untreated
group of experiment 1 had been used as
a benchmark the corresponding
changes would have been þ 8.51%
(Dermabase), þ33.34% (Dermovan),
14.86% (Eucerin) and þ8.23% (Va-
nicream). This, of course, would have
changed the findings of the study
completely.
The authors claim in their experi-
ments several other comparisons to
be statistically significant. In experi-
ment 1, for example, tumor volume
for nonmalignant tumors is claimed
to be significantly different from un-
treated with an increase of 63% for
Dermabase. In the same table, corres-
ponding increases of 262, 136, 64,
and 48% surprisingly are not signifi-
cant. This shows the enormous uncer-
tainty in the data and raises doubt
about the chosen sample size of 30
per group in experiment 2. Unfortu-
nately, a calculation of statistical power
for this group size is not given in the
paper.
Taken together, we have serious
doubts about the validity of the statis-
tical analysis and relevance of the
conclusions drawn from the results. It
is imperative that the experimenters
provide access to the individual data
sets for the scientific community to
enable valid and reliable reassessment
of their findings.
The study does not prove a relevant
causal relationship between the effects
occurring in mice and the use of the
tested skin care products.
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Table 1. Coefficients of variation for total tumors per mouse
Total no. of tumors per mouse
(value±SD)
Coefficient of
variation (%)
Water 4.57±5.48 119.91
Untreated 4.93±5.35 108.56
Combined Control 4.74±1.51 31.86
Dermabase 7.52±6.35 84.50
Dermovan 9.24±9.21 99.66
Eucerin 5.90±7.16 121.39
Vanicream 7.50±10.13 135.07
Custom Blend 4.88±5.95 121.93
Table 2. Two-sample tests comparison of treatment effects after 17 weeks
with untreated mice
Treatment
P value of two-sample t-test versus untreated
(assuming equal SDs)
Water 0.8032
Combined control 0.8037
Dermabase 0.1059
Dermovan 0.0386
Eucerin 0.5709
Vanicream 0.2439
Custom blend 0.9747
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